Amundi »

Day One Biopharmaceuticals I shares owned by Amundi

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by Amundi from 13F filings

Historical chart of Amundi investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by Amundi consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by Amundi

Quarter filed Position value Share count Share price at filing
2023-12-31 $43k 3.0k 14.49

More positions owned by Amundi

Apple (AAPL)
Amazon Commstck (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Adobe Systems Incorporated (ADBE)
Advanced Micro Devices Commstck (AMD)
Stellantis SHS (STLA)
Home Depot (HD)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Mastercard Cl A (MA)
Exxon Mobil Corporation (XOM)
Chevron Corporation (CVX)

View all positions for Amundi

Top funds holding Day One Biopharmaceuticals I

RA Capital Management
Atlas Venture Life Science Advisors
Vanguard Group
Franklin Resources
Braidwell
Viking Global Investors
T. Rowe Price Associates
Goldman Sachs Group
Deerfield Management Company
First Turn Management
Henderson Group
TimesSquare Capital Management
Partner Fund Management
Boxer Capital
Baker Bros. Advisors

View all funds holding Day One Biopharmaceuticals I